Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

FromRCVS Knowledge - Evidence-based Veterinary Medicine


Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

FromRCVS Knowledge - Evidence-based Veterinary Medicine

ratings:
Length:
3 minutes
Released:
Aug 23, 2023
Format:
Podcast episode

Description

In this Audio Summary, Bonnie looks at whether lokivetmab is more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system), in dogs with atopic skin disease. Read the full Knowledge Summary here. 
Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.
Released:
Aug 23, 2023
Format:
Podcast episode

Titles in the series (100)

Veterinary podcast. Our mission is to advance the quality of veterinary care for the benefit of animals, the public, and society. We are the charity partner of the Royal College of Veterinary Surgeons.